plasma sample – Page 15 – Communicable Diseases Research

Severity of COVID-19 at elevated exposure to perfluorinated alkylates

Research Article

Published on 2020-12-312022-10-28
Journal: PLoS ONE [Category] COVID-19, MERS, SARS,

HCoV-NL63 and SARS-CoV-2 Share Recognized Epitopes by the Humoral Response in Sera of People Collected Pre- and during CoV-2 Pandemic

Article

Published on 2020-12-142022-10-29
Journal: Microorganisms [Category] COVID-19,

IgA2 Antibodies against SARS-CoV-2 Correlate with NET Formation and Fatal Outcome in Severely Diseased COVID-19 Patients

SARS-CoV-2에 대한 IgA2 항체는 중증 COVID-19 환자의 NET 형성 및 치명적인 결과와 상관 관계가 있습니다

Communication

Published on 2020-12-122022-09-11
Journal: Cells [Category] MERS, SARS, 바이오마커, 진단,

[키워드] activate acute respiratory syndrome acute respiratory syndrome coronavirus Adaptive immune response anti-SARS-CoV-2 anti-SARS-CoV-2 IgG antibody antibody level antibody levels C-reactive protein C-reactive protein (CRP characterized circulating contribute Control coronavirus correlated COVID-19 CRP level CRP levels extracellular DNA Formation Hospitalization Host ICU IgA IgA2 IgG response IgG responses Immune cell immune cells induce Infection Inflammation intensive care intensive care unit leads less marker mild symptoms moderate moderate symptoms NET neutrophil Neutrophil extracellular trap neutrophil extracellular trap (NET) organ injury outcome Patient patient groups patients plasma sample plasma samples respiratory SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 spike protein SARS-CoV-2-infected patient SARS-CoV-2-infected patients SARS-CoV-2-specific IgG severe acute respiratory syndrome Coronavirus severe acute respiratory syndrome coronavirus 2 severe disease severe SARS severe SARS-CoV-2 specific antibodies Spike protein Symptom the strongest These data TRAP were measured while
[DOI] 10.3390/cells9122676 PMC 바로가기 [Article Type] Communication

The kinetics of humoral response and its relationship with the disease severity in COVID-19

체액 반응의 역학 및 COVID-19의 질병 중증도와의 관계

Article

Published on 2020-12-112022-09-10
Journal: Communications Biology [Category] MERS, SARS, 진단, 치료기술, 치료법,

[키워드] absorbance antibody Antibody Response Antibody titer Antibody titers appearance time caused collected coronavirus coronavirus 2 coronavirus disease Coronavirus disease 2019 Course COVID-19 COVID-19 patient Dilution disease disease course disease severity disease severity of COVID-19 domain enrolled geometric mean geometric mean titers global pandemic humoral Humoral response IgG IgG antibodies IgM IgM and IgG Immunoglobulin infections NAb NAbs neutralizing antibody nucleocapsid patients with COVID-19 plasma plasma sample plasma samples positive correlation RBD Receptor-binding domain respiratory risk factor SARS-CoV-2 severe acute respiratory syndrome Coronavirus severe acute respiratory syndrome coronavirus 2 Severe case severity severity of COVID-19 Spike protein Spike proteins Stage tested the antibody the disease the spike protein titers viral infection was measured was used were measured
[DOI] 10.1038/s42003-020-01526-8 PMC 바로가기 [Article Type] Article

Defining the features and duration of antibody responses to SARS-CoV-2 infection associated with disease severity and outcome

질병 중증도 및 결과와 관련된 SARS-CoV-2 감염에 대한 항체 반응의 특징 및 기간 정의

Research Articles

Published on 2020-12-072022-09-10
Journal: Science Immunology [Category] MERS, SARS, 진단, 치료법,

[키워드] ACE2 acute illness Affect analyzed angiotensin angiotensin-converting enzyme 2 antibody antibody levels Antibody Response Antibody responses Asymptomatic Asymptomatic individuals Clinical outcome clinical outcomes Cohort correlated COVID-19 COVID-19 patients decrease decreases disease severity ELISA feature FIVE hospitalized COVID-19 patient Host IgG IgG antibodies IgG antibody IgG titer illness Illness severity in viral increase Interaction mild illness Most patients Neutralization assay neutralize nucleocapsid antigen observation outcome outcomes Outpatient outpatients Patient patients patients died plasma antibody plasma sample Post-infection predict Pseudovirus neutralization assays RBD RBD domain RBD-ACE2 receptor Receptor binding domain responses SARS-CoV-2 antibodies SARS-COV-2 infection SARS-CoV-2-specific antibodies serological serological response severely ill patients severity specific antibodies specificity Viral viral spike virus
[DOI] 10.1126/sciimmunol.abe0240 PMC 바로가기 [Article Type] Research Articles

Ultra-Sensitive Serial Profiling of SARS-CoV-2 Antigens and Antibodies in Plasma to Understand Disease Progression in COVID-19 Patients with Severe Disease

중증 질환이 있는 COVID-19 환자의 질병 진행을 이해하기 위한 혈장 내 SARS-CoV-2 항원 및 항체의 초민감 직렬 프로파일링

Article

Published on 2020-12-012022-09-11
Journal: Clinical Chemistry [Category] MERS, SARS, 진단, 치료기술, 치료법,

[키워드] 95% CI acute respiratory syndrome acute respiratory syndrome coronavirus analyzed anti-SARS-CoV-2 Antigen Biomarker Blood changes in clearance clinical outcomes Clustering Combined Concentration coronavirus coronavirus disease COVID-19 COVID-19 case COVID-19 negative COVID-19 positive patients detect detectable Disease progression Hierarchical hierarchical clustering ICU admission identify Infection intubation longitudinal plasma samples molecule MONITOR N antigen nasopharyngeal nucleocapsid antigen nucleocapsid antigens Patient patients patients with COVID-19 PCR plasma plasma sample positive positive result Profiling quantified reported respiratory Respiratory failure RT-PCR test S1 subunit SARS-CoV-2 SARS-CoV-2 antigen SARS-CoV-2 S1 SARS-CoV-2 spike SARS-CoV-2 viral Seroconversion serological serological assays serology tests severe acute respiratory syndrome Coronavirus severe acute respiratory syndrome coronavirus 2 severe disease Simoa single molecule arrays statistically significant test results These data Viral Viral antigen viral antigens
[DOI] 10.1093/clinchem/hvaa213 PMC 바로가기 [Article Type] Article

Cardiac troponin I in SARS-CoV-2-patients: The additional prognostic value of serial monitoring

SARS-CoV-2-환자의 심장 트로포닌 I: 연속 모니터링의 추가적인 예후 가치

Article

Published on 2020-12-012022-09-11
Journal: Clinica chimica acta; international journal of cli [Category] MERS, SARS, 바이오마커,

[키워드] 113 patient 113 patients Abbott Abbott Diagnostics Admission approach Architect Biomarkers cardiac cardiac complication Cardiac complications cardiac troponin carried Clinical management clinically consecutive patient described died disease Diseases epidemiological female FIVE five groups group heparin High-sensitivity Troponin I Hospital stay hypoxia ICU information Injury kinetic Kinetic release lithium Major male median Microbiology pandemic disease Patient plasma sample plasma samples Prognosis Prognostic value risk SARS-CoV-2 SARS-CoV-2 patient SARS-CoV-2 patients sensitive sensitivity Serial monitoring. severe hypoxia STAT troponin troponin I Variation
[DOI] 10.1016/j.cca.2020.09.036 PMC 바로가기 [Article Type] Article

Prevalence of Severe Acute Respiratory Syndrome Coronavirus 2 Neutralizing Antibodies in Egyptian Convalescent Plasma Donors

Microbiology

Published on 2020-11-242022-10-31
Journal: Frontiers in Microbiology [Category] COVID-19,

Long-Term SARS-CoV-2 Infection Associated with Viral Dissemination in Different Body Fluids Including Bile in Two Patients with Acute Cholecystitis

Case Report

Published on 2020-11-232022-10-29
Journal: International Review of Cell and Molecular Biology [Category] COVID-19,

Antibody Responses to SARS-CoV-2 in Patients With Novel Coronavirus Disease 2019

신종 코로나바이러스 감염증 2019 환자의 SARS-CoV-2에 대한 항체 반응

Article

Published on 2020-11-192022-09-11
Journal: Clinical Infectious Diseases: An Official Publicat [Category] SARS, 진단, 치료기술,

[키워드] analyzed antibody Antibody detection Antibody Response Antibody testing blood sample Blood samples clinical information collected Course COVID-19 COVID-19 patients demonstrated Diagnosis disease dynamics of antibody early phase enrolled Hospitalization IgG IgM infected patient infected patients Infection lack management median novel Novel coronavirus novel coronavirus SARS-CoV-2 offer pathogenic Patient patients patients with SARS-CoV-2 plasma sample presence of antibody reason reason for response RNA SARS-CoV-2 SARS-COV-2 infection sensitivity seroconversion rate seroconversion rates seroconversion time Serological testing significantly Support tested total antibodies total antibody virus
[DOI] 10.1093/cid/ciaa344 PMC 바로가기 [Article Type] Article